$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Home
Oncology
Oncology
What does erlotinib do? Is Erlotinib treatment effective?
2025-10-19 11:44:20
Check Details
First-line treatment for recurrent non-small cell lung cancer—everolimus Afinitor_ Kanghule
2025-10-19 11:44:20
Check Details
Are lung cancer patients the same among smokers and non-smokers?
2025-10-19 11:44:20
Check Details
EGFR exon 20 mutations usher in the first oral targeted drug, mobotinib
2025-10-19 11:44:20
Check Details
Efficacy and safety data of Rybrevant in the treatment of lung cancer show anti-tumor activity!
2025-10-19 11:44:20
Check Details
Where can I buy Rybrevant? What is the dosage of Rybrevant?
2025-10-19 11:44:20
Check Details
Can dacomitinib be reimbursed by medical insurance? What should I pay attention to?
2025-10-19 11:44:20
Check Details
FDA announces that Rybrevant, the first targeted drug for lung cancer EGFR20ins, has been approved for marketing
2025-10-19 11:44:20
Check Details
How to use Rybrevant? How long does it take for resistance to develop?
2025-10-19 11:44:20
Check Details
Where can I buy the third-generation ALK inhibitor lorlatinib? What is the effect?
2025-10-19 11:44:20
Check Details
What is the dosage of lorlatinib? What are the side effects?
2025-10-19 11:44:20
Check Details
Targeted drug treatment of EGFR gene mutation lung cancer (1)
2025-10-19 11:44:20
Check Details
1
2
...
3971
3972
3973
3974
3975
3976
3977
...
4149
4150
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Detailed introduction to the instruction manual of revumenib
2
Ryeqo (Relugolix compound tablets) - long-term treatment for uterine fibroids
3
How effective is Ryeqo (Relugolix compound tablets)?
4
U.S. FDA approves Ryeqo to treat menorrhagia related to uterine fibroids in premenopausal women!
5
How much does Ryeqo cost? Where can I buy it in Liaoning?
6
Ryeqo - a good medicine that can effectively improve menorrhagia and pain caused by uterine fibroids
7
How much does Ryeqo cost? Is it available in Shandong now?
8
Comprehensive summary-the advantages, disadvantages and indications of different preparations of estradiol
9
What is the therapeutic effect of myfembree
10
What are the serious side effects of myfembree and how to deal with them?
11
How effective is Ryeqo in treating uterine fibroids?
12
How to use Ryeqo correctly?